South Korea Cancer Diagnostic Market Insight
Published: 19 June 2026 | Report Format: Electronic (PDF) | Author: Sanket and Pranali
The South Korea cancer diagnostic market is expected to grow at a CAGR of 6.05% due to rising chronic disease prevalence, rapid molecular diagnostics adoption, expanding healthcare infrastructure, and advanced lab screening deployment
South Korea Cancer Diagnostic Market Insights Forecasts to 2035
- The South Korea Cancer Diagnostic Market Size Was Estimated USD 1.50 Billion in 2025
- The Market Size is Expected to Grow at a CAGR of around 6.05% from 2025 to 2035
- The South Korea Cancer Diagnostic Market Size is Expected to rise around USD 2.70 Billion by 2035
Notable Insights for the South Korea Cancer Diagnostic Market
- The Molecular Diagnostics & Advanced Genetic Testing segment secured a dominant 54% market share in 2025, driven by high adoption across South Korea's metropolitan clinical centers and automated hospitals.
- Fueled by rising demand for localized, rapid testing options and high-yield screening efficiency, Point-of-Care Diagnostics led the domestic industry in 2025 with a dominant 57% market share.
- Driven by strong global demand for clinical chemistry analyzers and automated immunoassay platforms, Seegene Inc. projected its fiscal year 2025 worldwide corporate revenue at approximately $1.8 billion.
- Market growth accelerates as medical laboratories modernize, utilizing automated screening workflows and resource-efficient assay methods to achieve 34% cost savings and reduce diagnostic error rates by 27%.
Download the eBook (ToC)
Why Buy This Report
- Gives an in-depth analysis of the impact of trends in controlled-environment clinical screening, modernization in medical laboratory systems, and development in automated assay technology on the South Korea Diagnostic Market growth.
- Provides strategic insights regarding technology innovation such as automated specimen delivery, artificial intelligence-based pathology diagnostics, smart molecular assay tools, and real-time disease outbreak monitoring technology.
- Assists players to analyze competitive benchmarking, investment in advanced bio-cultivation systems, automation in central laboratories, and expansion in specialized screening facilities by major molecular diagnostic suppliers.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the South Korea Cancer Diagnostic Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in South Korea Cancer Diagnostic Market
- Seegene Inc.
- SD Biosensor, Inc.
- Macrogen, Inc.
- Bioneer Corporation
- Humasis Co., Ltd.
- Sugentech, Inc.
- Access Bio, Inc.
- Genematrix Inc.
- LabGenomics Co., Ltd.
- PCL Inc.
Recent Developments:
- In October 2025, SD Biosensor introduced smart AI-enabled molecular diagnostic screening systems integrated with cloud-based automated interpretation technologies for precise infectious disease management operations.
- In July 2025, Seegene Inc. launched next-generation modular syndromic testing systems optimized for clinical commercial laboratories, automated specimen preparation, and disease tracking applications requiring high-yield accuracy.
Market Segmentation:
South Korea Cancer Diagnostic Market, By Test Type
- Molecular Diagnostics
- Clinical Chemistry
- Immunoassays
- Point-of-Care Testing (POCT)
- Tissue Diagnostics
South Korea Cancer Diagnostic Market, By Technology
- AI-Based Digital Pathology
- PCR & Nucleic Acid Amplification
- Next-Generation Sequencing (NGS)
- Microfluidic Biochips
- Automated ELISA Platforms
South Korea Cancer Diagnostic Market, By Application
- Infectious Diseases
- Oncology & Cancer Screening
- Cardiovascular Biomarkers
- Genetic Testing
- Metabolic Profiles
Expert Views:
The market for Cancer diagnostics in South Korea will grow owing to the rise in the demand for high yield medical testing systems, the growing number of modernization of commercial laboratories, and increasing demand for automated screening solutions. The inclusion of artificial intelligence based diagnostic regulation solutions, Internet of Things enabled patient tracking systems, and advanced precision sensors will enhance operational efficiency and boost the demand for clinical testing systems in the South Korean market.
Author: Sanket and Pranali By Decisions Advisors and Consulting